Vanderbilt's Alexander Bick, MD, PhD, has received a Hevolution/AFAR New Investigator Award in Aging Biology and Geroscience Research from the American Federation for Aging Research (AFAR) and Hevolution Foundation.

An analysis of the genomes of more than 1 million people of European ancestry, conducted by several of the world’s leading genomic centers, including Vanderbilt University Medical Center, has identified more than 2,000 independent genetic signals for blood pressure.

A Vanderbilt study found that Black and white people who earned less than $15,000 a year died, on average, more than 10 years earlier than those whose annual income exceeded $50,000.

An anticancer drug blunted atherosclerosis progression — and even made plaques shrink — in a mouse model of the disease, opening new opportunities for preventing and treating this leading cause of death.

Vanderbilt University Medical Center has been awarded a seven-year, $5 million award to conduct food allergy research, joining nine other institutions as part of the Consortium for Food Allergy Research.

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.